Psychosocial stress plays an important role in the development and manifestation of borderline personality disorder (BPD). Early life stress and traumatization are risk factors for BPD, and reports of traumatic childhood abuse are frequent in patients with BPD.
studies of BPD are rather mixed (for example, see the review by Zimmerman and Choi-Kain 8 ). Comorbid disorders, such as posttraumatic stress disorder (PTSD) and major depressive disorder (MDD), which are frequent among patients with BPD and affect HPA axis functioning, as well as other confounding variables, such as sex, menstrual cycle and age, may at least partly explain these inconsistencies. 8 The cause of HPA axis dysregulations is thought to result from adverse experiences in early life, with traumatic childhood experiences and sexual abuse in childhood impairing neurobiological systems involved in the stress response. 9, 10 In addition to disturbances in HPA axis functioning, brain imaging studies have revealed volumetric alterations in structures crucially involved in the regulation of stress responses in patients with BPD. Across studies, patients with BPD have shown reduced hippocampal and amygdalar volumes (although results are less consistent for the latter; for example, see the meta-analysis by Nunes and colleagues 11 ). The hippocampus and amygdala have inverse regulatory effects on the hypothalamic stress response. Whereas the hippocampus inhibits hypothalamic and HPA axis activity, 12 the amygdala exhibits activating effects on the HPA axis and stimulates glucocorticoid release. 13 Amygdalar hyperactivity and reduced prefrontal amygdalar inhibition to (negative) emotional stimuli is also one of the most consistent findings of functional brain imaging studies of BPD 14 (for example, see the review by Mauchnik and Schmahl 15 ). In addition, some studies found reduced volumes in prefrontal brain areas involved in stress regulation, 13 in particular the anterior cingulate cortex (ACC) and orbitofrontal cortex. 16, 17 Thus, there is evidence for increased stress vulnerability, disturbed HPA axis functioning and alterations in the size and activation of structures involved in central stress regulation in patients with BPD. However, so far nothing is known about alterations in hypothalamic volume of patients with BPD. This is astonishing, as the hypothalamus is the main structure connecting the central nervous system to the endocrine system 13 and represents a link between endocrine and behavioural processes. 18 The aim of the present structural magnetic resonance imaging (MRI) study was to investigate grey matter alterations of central stress-regulating structures in women with BPD by applying a DARTEL voxel-based morphometry (VBM) algorithm. Voxel-based morphometry is an objective, automated method, secure of bias and interrater inaccuracy. It involves a voxel-wise comparison of local grey matter concentration between 2 groups. 19 We first performed an exploratory analysis on the whole brain volume. Owing to their influence on stress response, the hippocampus, amygdala and ACC represent the main target points for structural neuro imaging studies investigating central stress regulation. 20 Based on prior findings, we hypothesized that patients with BPD would have smaller volumes in the hippocampus, and most probably in the amygdala and the ACC, than healthy women. We also expected that patients with BPD would differ with respect to hypothalamic volume in comparison to healthy women. To test these hypotheses, we determined distinct a priori regions of interest (ROIs). We then explored whether grey matter volume of these 4 structures is associated with childhood trauma. To our knowledge, this is the first study analyzing hypothalamic grey matter alterations using DARTEL VBM in patients with BPD.
Methods

Participants
We recruited right-handed, unmedicated female patients with BPD between 18 and 35 years of age and healthy controls matched for age, IQ and education. Patients were recruited at the Department of General Psychiatry at the University of Heidelberg and through advertisement and were included in the study after confirmation of diagnosis. Healthy participants were also recruited through advertisement. We excluded individuals with a lifetime diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder or substantial neurologic disease; current alcohol/drug dependence; an IQ of 85 or lower; or hormonal or neurologic disorders as well as those who were pregnant. All patients with BPD had a DSM-IV-defined diagnosis of BPD, and none of the healthy participants had a current psychiatric disorder, had ever received a psychiatric diagnosis, or had ever undergone any psychological or psychiatric treatment. The study was approved by the Ethics Committee of the Faculty of Medicine, University of Heidelberg. All participants gave written informed consent after the study procedures were fully explained to them and before participation. This study was part of a larger study investigating neuropeptides in patients with BPD.
Measures
We assessed the diagnosis of BPD as well as comorbidity or absence of Axis II disorders using the German version of the International Disorder Examination for DSM-IV. 27 Comorbidity or absence of Axis I disorders and the Global Assessment of Functioning (GAF) score were assessed with the German version of the Structured Clinical Interview for DSM-IV (SCID-I). 26 Qualified diagnosticians (K.B. and I.S.) conducted the interviews. Four subtests of the German version of the Hamburg-Wechsler Intelligence Test 29 were used to provide an estimate for intelligence (IQ). We also used the Borderline Symptom List-23 (BSL-23) 23 to assess borderline symptom severity, the Beck Depression Inventory (BDI) 21 to measure depressive psychopathology, the Barratt Impulsiveness Scale (BIS-11) 22 to assess impulsive personality traits, the trait scale of the State-Trait Anger Expression Inventory (STAXI) 28 to measure trait levels of anger, and the Questionnaire for the Assessment of Factors of Aggression (FAF) 25 and the Childhood Trauma Questionnaire (CTQ) 24 to assess traumatization history. Healthy controls underwent the same diagnostic assessments as the patients. 
Magnetic resonance imaging procedures
Data analysis
Volumetric data were analyzed with SPM8 (Statistical Parametric Mapping, Wellcome Trust Center for Neuroimaging, www.fil.ion.ucl.ac.uk/spm) using the diffeomorphic registration algorithm implemented in the DARTEL toolbox for SPM8, 30 which has been found to improve the sensitivity and accuracy of such analysis in comparison to standard SPM. 31, 32 After the manual setting of the origin (anterior commissure) using the display tool, images were segmented into grey matter, white matter and cerebrospinal fluid using the unified segmentation model included in SPM8. 33 The resulting grey and white matter files were imported into the DARTEL procedure. The outputs were rigidly aligned tissue class images, resliced to 1.5 × 1.5 × 1.5 mm 3 voxel size. Next, we created a studyspecific brain template from the individual tissue class images of all participants. A modulation was installed to correct for changes in volume induced by nonlinear normalization. The DARTEL processed images were spatially normalized to Montreal Neurological Institute (MNI) space. The images were smoothed using a 4 mm full-width at half-maximum Gaussian kernel, which gives consideration to the small size of the hypothalamus and amygdala. We then used these smoothed, modu lated and normalized images for statistical analyses.
Statistical analysis
We compared demographic and psychometric characteristics of patients and controls using χ 2 tests for categorical variables and 2-sample t tests for continuous variables. Statistical analyses were performed using SPSS software version 17.
For volumetric data, we calculated 2-sample t tests to compare patients with BPD and controls. Images were thresholded at an absolute level of 0.1, and therefore only voxels that exceeded the threshold were included. To account for volumetric variability associated with individual head size, total intracranial volume was entered into the design matrix as a covariate. Total intracranial volume was obtained by summing the volumes of grey matter, white matter and cerebrospinal fluid using the function "get_totals" (www .cs .ucl .ac .uk /staff /G .Ridgway /vbm/). To correct for multiple comparisons in whole brain analyses, results were considered to be significant at p < 0.05, family-wise error (FWE)-corrected. Additionally, a threshold for voxel cluster size of at least k = 10 voxels was chosen. In a second step, we performed an ROI analysis of the hippocampus, amygdala, ACC and hypothalamus. Provided that an an priori hypothesis is made, ROI analyses are more sensitive than whole brain analysis. Masks for these analyses were derived from Wake Forest University WFU Pickatlas (www.ansir.wfubmc.edu/). We considered results to be significant at p < 0.05, FWE-corrected. In an additional analysis, the BPD group was divided into patients with and without comorbid PTSD to test influences of this comorbidity on our ROIs. In a third step, we calculated a regression analysis with the individual results of the CTQ for the BPD group. The total scores of the CTQ were inserted in the design matrix as a covariate to explore whether hypothalamic volume is associated with the extent of traumatic childhood experience. Additional regression analyses with individual IQ, BDI, BIS, BSL, FAF and STAXI scores and the volumes in our ROIs (amygdala, hippocampus, ACC and hypothalamus) were performed to check for influences of these psychometric variables in the BPD group.
Results
Participant demographic and psychometric data
We enrolled 30 women with BPD and 33 controls in our study. Nine patients came from the Department of General Psychiatry at the University of Heidelberg (5 inpatients, 4 outpatients) and 21 were recruited through advertisements. Patients and controls did not differ significantly for age, IQ and education (all t 61 ≤ 1.18, p ≥ 0.49; Table 1 ). As expected, patients with BPD scored higher than controls in all psychometric ratings (except for STAXI and anger control; Table 1 ). Comorbid psychiatric diagnoses of the BPD group included depression (n = 20 [9 acute]); PTSD (n = 9); remitted substance abuse (n = 8); anxiety disorders (n = 10); eating disorders (n = 9); adjustment disorder (n = 1); and paranoid (n = 4), antisocial (n = 2), histrionic (n = 2), narcissistic (n = 2), compulsive (n = 2), dependent (n = 2) and avoidant (n = 2) personality disorders.
Imaging findings
The results of the whole brain analysis are listed in Table 2 . Only results surviving a significance level of p < 0.05, FWEcorrected, were considered to be relevant. Patients with BPD showed significantly reduced grey matter volume in the left hippocampus, vermis 10, parietal inferior left gyrus and temporal mid left/occipital mid left gyrus. In addition, patients with BPD showed significant increases in grey matter volume in the putamen bilaterally and in the Heschl right/ temporal superior right gyrus.
Region of interest analyses were conducted for the hippocampus, amygdala, ACC and hypothalamus (Table 3) . Patients with BPD had significantly decreased grey matter concentration in the right and left hippocampus. The spatial location of the between-group difference was similar in both the left and right hippocampus. However, no significant difference was detected in the amygdala and the ACC. In addition, patients with BPD had significantly increased grey matter volume in the left hypothalamus (Fig. 1) . Comparisons between subgroups of patients with BPD with and without PTSD did not reveal any significant differences in brain morphology.
The scores in the CTQ were positively correlated with hypothalamic grey matter volume (r = 0.58, p = 0.001). The spatial location of the correlating areas was similar in the right and left hypothalamus. No correlation was found between CTQ scores and grey matter volumes in the hippocampus, amygdala and ACC. Additional regression analyses revealed no further significant correlations between clinical variables (i.e., IQ, GAF, BDI, BIS, BSL, FAF and STAXI scores) and grey matter volumes in our predefined ROIs in the BPD group.
Discussion
Applying DARTEL VBM, we were able to demonstrate new evidence for increased grey matter volume in the hypothalamus and decreased hippocampal volume in women with BPD compared with healthy women. Covarying for the extent of traumatic childhood experience (CTQ) delivered a positive correlation of hypothalamic volume and CTQ scores in patients with BPD.
Reduction of hippocampal volume has consistently been reported in patients with BPD. Two studies found that hippocampal volume loss was more pronounced in patients with BPD who experienced childhood trauma than in healthy controls 34 or patients with BPD who did not experience childhood trauma. 35 Hippocampal volume loss has been associated with stress and glucocorticoid admission, which can be explained by a high expression of glucocorticoid receptors in this structure. 12, 36 The fact that we did not find any correlation between hippocampal grey matter volume and CTQ scores in our patients indicates that the extent of childhood trauma had no direct influence on hippocampal grey matter volume in patients with BPD in our study. This is different from data reported by Dannlowsky and colleagues 37 in healthy adults; they found a negative correlation between CTQ scores and hippocampal volume.
In the present study, CTQ scores were positively correlated with grey matter volume in the hypothalamus of patients with BPD, indicating increased hypothalamic volumes in patients with a history of traumatization. According to the atlas by Baroncini and colleagues, 38 the alterations found by our group are, in fact, localized in the hypothalamus. To our knowledge, ours is the first study reporting alterations in hypothalamic grey matter volume in patients with BPD. This is astonishing, as the hypothalamus is not only regarded as one of the key structures of central stress regulation, but also represents an important link between the endocrine system and behavioural reactions, such as fight and flight. has been reported to lead to increased corticotropin-releasing hormone (CRH) mRNA expression 9 and exaggerated glucocorticoid response to subsequent stressors. 39 Depressed patients also show heightened CRH mRNA levels, 40 and an increased total number of CRH neurons has been reported in patients with mood disorders. 41 Similar mechanisms might be involved in traumatized individuals and may account for the hypothalamic grey matter alterations found in our BPD sample. Dysfunctions of the amygdala may be an additional explanation for increased hypothalamic CRH expression. The amygdala evaluates the environment for potential dangers and threats, 42 and amygdala activation to threat-related facial expressions correlates with CTQ scores. 37 This may suggest that traumatic experiences in childhood lead to a hyperreagibility of the amygdala to threatening stimuli in adulthood, which has been reported in patients with BPD. 43 As the amygdala sustains connections to the hypothalamus, its increased activity could generate an exaggerated stimulation of the HPA axis, increasing glucocorticoid secretion. 13 The hippocampus, on the other hand, is a structure particularly damaged by glucocorticoid neurotoxicity due to multiple glucocorticoid receptors. 36 Hippocampal damage might lead to the inability of the individual to terminate HPA axis response to stress, 13 which is supported by the finding that cortisol response to a stress task correlates with hippocampal volume. 44 Taken together, amygdalar hyperactivity and hippocampal damage may lead to increased hypothalamic and HPA axis activity. Increased hypothalamic activity could result in increased grey matter volume and explain HPA axis alterations. The positive correlation between the extent of traumatic childhood experience and hypothalamic grey matter volume supports this hypothesis. Corticotropin-releasing hormone binding sites in the pituitary gland may be reduced to protect the organism from the toxic effects of glucocorticoids, 45 which could explain hypocortisolism in children exposed to traumatic experiences 46 and the blunted response of adrenocorticotropic hormone to CRH in traumatized women. 9 In fact, pituitary volume seems to be associated with childhood trauma as well as parasuicidal behaviour in teenagers with BPD, which could be the consequence of severe stress during childhood and reflect a hyperactive HPA axis in individuals with this disorder. 47, 48 Contrary to this explanation and our findings, rodents have shown reduced numbers of cells in the parvocellular part of the hypothalamic paraventricular nucleus after 10 days of neonatal handling. 49 Despite this reduction in cell number, the volume of the nuclei remained unchanged, indicating that cell loss does not directly lead to volume loss. It also has to be considered that the rodent brain at birth is far less developed than the human brain, which complicates the translation of animal to human studies. 10 Moreover, childhood trauma is more complex than animal models of early stress, and more factors need to be taken into account. 50 We did not find a difference in hypothalamic volume between patients with and without PTSD. As only 9 of our 30 patients had a diagnosis of PTSD, the statistical power of this comparison remains weak and deters us from strong conclusions.
Contrary to our expectations, we did not find significant grey matter alterations in the amygdala and ACC. The literature, however, provides heterogeneous results on both structures. Concerning the amygdala, some studies reported a decreased volume, 35 some did not find any significant difference [51] [52] [53] and others revealed increased amygdalar volume in patients with BPD. 16 This inconsistency may at least partly be due to small sample sizes, psychotropic medications and comorbidities. 11 Zetzsche and colleagues, 52 for instance, found increased amygdalar volumes in patients with BPD who had comorbid MDD compared with those without MDD. The heterogeneity of results is even greater for volumetric alterations in the ACC. Recent VBM studies have provided evidence for reduced volumes in a sample of male and female patients with BPD, 16, 54, 55 reduced volumes in male but not in female patients with BPD, 17 and no volumetric alterations at all. 56 The high morphometric variability of the ACC makes spatial normalization in VBM more difficult and susceptible to errors. 57, 58 If regional morphological differences exist, these are minimized by the VBM registration algorithm, 59 which may explain heterogeneous results for ACC volume in patients with BPD. In addition, age effects resulting from differential developmental effects on brain areas may contribute to heterogeneity in morphometric data in patients with BPD since reduced ACC volume, but no abnormalities of the hippocampus and amygdala, have been reported in adolescent patients with a first presentation of BPD. 57, 60 The increase in grey matter volume in the putamen of our patients with BPD is consistent with the results of Brambilla and colleagues. 34 In this study, alterations in the putamen/ basal ganglia were particularly pronounced in patients with BPD and current substance abuse. Current substance abuse was an exclusion criterion in the present study, and comparing participants with remitted substance abuse to those without revealed no significant differences. The putamen and the basal ganglia are involved not only in planning and execution of movement, but also in higher cognitive functions, such as attention and decision-making, 61 which at least in some studies have been reported to be impaired in patients with BPD. 62 We also found reduced grey matter in the cerebellar vermis. Recent findings suggest a major involvement of cerebellar structures in emotional behaviour, 63 which is mediated by reciprocal connections to structures of the limbic system. 64 Reduced vermal volume has already been reported in patients with bipolar disorder and PTSD, 65, 66 suggesting an involvement in the pathology of psychiatric disorders. Schraa-Tam J Psychiatry Neurosci 2013;38(2) and colleagues 67 found prominent activation of the vermis while healthy participants viewed negative facial expressions. The vermis might thus be involved in an individual's reactions to another person's negative facial expressions. As patients with BPD are hypervigilant to negative stimuli, 68 vermal alterations could represent a morphological correlate of the reactions of patients with BPD to negative facial expressions.
The present study also revealed volumetric alterations in the left inferior parietal gyrus, the left middle temporal gyrus and the right Heschl gyrus. Reductions in the inferior parietal lobe are in line with the findings of Brunner and colleagues 69 in adolescent patients with BPD. In a recently published study, patients with BPD showed decreased connectivity of the left inferior parietal lobe and right middle temporal regions compared with healthy controls, 70 which was interpreted as a biological substrate of a decreased attentional capacity for relevant somatosensory stimuli. Changes in grey matter volume in the parietal lobe could explain attentional capacity deficits described in patients with BPD. 62 The Heschl gyrus is located in the primary auditory cortex and is involved in the processing of auditory information. 71 Studies addressing the involvement of the auditory system in patients with BPD have been scarce. However, there is evidence for auditory processing abnormalities in children with BPD. 72 Comparable with our findings, Goldstein and colleagues 73 reported increased grey matter volume in the Heschl gyrus of patients with BPD, which might reflect compensatory mechanisms for dysfunctions in the processing of auditory information. The middle temporal gyrus is another structure involved in auditory processing, 71 in which volumetric reductions have previously been reported in patients with BPD. 17 Taken together, these findings suggest alterations in structures of the central auditory system in patients with BPD that need to be addressed in further studies.
Our study has several strengths, as it expands on other studies in the field by investigating volumetric alterations in central stress-regulating structures of female patients with BPD. We used DARTEL VBM, a fully automated and sensitive technique, which is independent of rater inaccuracy and biases, to assess morphometric alterations between wellmatched and relatively large, unmedicated samples of women with and without BPD.
Limitations
Some limitations have to be addressed. First, even though our study has a reasonable sample size, negative results could be a consequence of small statistical power. Second, our findings are limited by the lack of measures of CRH, adrenocorticotropic hormone and cortisol levels. Further studies are thus needed to replicate our findings and to address the association between hypothalamic volume and HPA axis activity and reactivity to stress. Third, psychiatric comorbidities were prevalent in our sample and might have confounded the results. The high frequency and number of comorbidities in patients with BPD, however, belongs to the clinical picture of this disorder, and excluding patients with comorbid disorders would not be representative of the clinic al population. Future studies should therefore include clin ical control groups and compare grey matter volumes of patients with BPD and patients with MDD or PTSD to examine the specificity of volumetric alterations in central stress-regulating structures, such as the hypothalamus and hippocampus. The hypothalamus is a structure that contains many specialized cell groups, 38 and future studies should investigate alterations of these different subgroups in particular.
Conclusion
Taken together, our results provide new evidence for grey matter alterations in the hypothalamus and replicate previously reported decrements in hippocampal grey matter in patients with BPD that may be induced by experiences of early life stress. As there have been no other studies on hypothalamic volume and activity in patients with BPD, more research is needed to investigate the nature of this finding. Understanding the role of the hypothalamus and other structures of the stress-regulating system could help us to further understand the neurobiological underpinnings of this complex disorder.
